Business Wire

Walgreens and Kaléo Partner to Address Epinephrine Auto-Injector Supply Issues, Providing Patients Access to AUVI-Q® (epinephrine injection, USP) Through Walgreens Locations ...

For more information, visit www.kaleo.com. About AUVI-Q (0.3 mg, 0.15 mg and 0.1 mg) AUVI-Q (epinephrine injection, USP) Auto-injector is a prescription medicine used to treat emergency allergic ...
Business Wire

CORRECTING and REPLACING FDA Approves Kaléo’s 10 mg Naloxone Auto-Injector for the Treatment of Known or Potential Exposure to Ultra-Potent Weaponized Opioids

RICHMOND, Va.--(BUSINESS WIRE)--Please replace the release dated March 2, 2022, with the following corrected version due to multiple revisions. The updated release ...
Richmond

Kaleo auto-injector for infants approved

Richmond-based pharmaceutical company Kaléo has received federal approval to market an epinephrine auto-injector to treat life-threatening allergic reactions in babies as small as 16.5 pounds.
Virginia Business

FDA approves Kaleo’s epinephrine auto-injector for infants and children

The U.S. Food and Drug Administration (FDA) has approved Richmond-based Kaléo’s supplemental drug application for the first epinephrine auto-injector specifically for infants and children with serious ...
Richmond

Richmond-based Kaleo gets its epinephrine auto-injectors into Walgreens and in Canada

Kaleo, the Richmond-based pharmaceutical company that produces an epinephrine auto-injector to treat severe allergic reactions, is expanding its reach into Canada and into one of the largest pharmacy ...